Skip to main content
Log in

Nitric Oxide, Oxidant Status and Antioxidant Response in Morbidly Obese Patients: the Impact of 1-Year Surgical Weight Loss

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

The aims of this study were to evaluate nitric oxide (NO) metabolites (nitrite/nitrate NO x ) as proinflammatory parameter and total oxidant status (TOS) as well as total antioxidant response (TAR) as oxidative stress (OS) markers in morbidly obese (MO) patients in comparison with normal-weight healthy (NWH) subjects and to determine the post-bariatric surgery changes of NO x and OS indicators in relation with weight loss.

Methods

We examined serum NO x , TOS, and TAR in a bariatric group of MO patients and a NWH control group (n = 23 each group). In the NWH group, serum was examined once, while in the MO group, serum was examined before and at 3, 6, and 12 months after silastic ring vertical gastroplasty (SRVG).

Results

Serum NO x and TOS values were higher (p < 0.001), while TAR level was lower (p < 0.001) in MO patients as compared to the NWH group. No significant changes occurred at 12 months after surgery in the MO group as far as the NO x (p = 0.93), TOS (p = 0.11), and TAR (p = 0.15) levels were concerned as compared to baseline values. However, NO x increased at 6 months after surgery (p < 0.008) and then decreased by the 12th month after SRVG (p < 0.008), reaching almost baseline values.

Conclusions

At baseline, there was a high production of proinflammatory and OS markers in MO patients. SRVG surgical weight loss was not accompanied by significant changes of these parameters at 1 year after surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Low S, Chew Chin M, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singapore. 2009;38:57–65.

    PubMed  Google Scholar 

  2. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010;535918:1–17.

    Article  Google Scholar 

  3. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12:3117–32.

    Article  PubMed  Google Scholar 

  4. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16.

    Article  PubMed  CAS  Google Scholar 

  5. Martínez JA. Mitochondrial oxidative stress and inflammation: a slalom to obesity and insulin resistance. J Physiol Biochem. 2006;62(4):303–6.

    Article  PubMed  Google Scholar 

  6. Keaney JF, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434–9.

    Article  PubMed  CAS  Google Scholar 

  7. Kwang KK, Pyung CO, Quon MJ. Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res. 2009;81:649–59.

    Google Scholar 

  8. Avogaro A, de Kreutzenberg SV. Mechanisms of endothelial dysfunction in obesity. Clinica Chimica Acta. 2005;360:9–26.

    Article  CAS  Google Scholar 

  9. Noroha BT, Li JM, Wheatcroft SB, et al. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes. 2005;54:1082–9.

    Article  Google Scholar 

  10. Joost HG, Tschop MH. NO to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity? Endocrinology. 2007;148(10):4545–7.

    Article  PubMed  CAS  Google Scholar 

  11. Iyer A, Fairlie DP, Prins JB, et al. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol. 2010;6:71–82.

    Article  PubMed  CAS  Google Scholar 

  12. Grattagliano I, Palmieri VO, Portincasa P, et al. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem. 2008;19:491–504.

    Article  PubMed  CAS  Google Scholar 

  13. Ward M, Prachand V. Surgical treatment of obesity. Gastrointest Endosc. 2009;70(5):985–90.

    Article  PubMed  Google Scholar 

  14. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.

    Article  PubMed  Google Scholar 

  15. Deitel M. The early effect of the bariatric operations on diabetes. Obes Surg. 2002;12:349.

    Article  PubMed  CAS  Google Scholar 

  16. Lin LY, Lee WJ, Shen HN, et al. Nitric oxide production is paradoxically decreased after weight reduction surgery in morbid obesity patients. Atherosclerosis. 2007;190:436–42.

    Article  PubMed  CAS  Google Scholar 

  17. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J, et al. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity. Metabolism. 2004;53(10):1268–73.

    Article  PubMed  CAS  Google Scholar 

  18. Pardina E, Ferrer R, Baena-Fustegueras JA, et al. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg. 2010;20:623–32.

    Article  PubMed  Google Scholar 

  19. Sledzinski T, Sledzinski M, Smolenski RT, et al. Increased serum nitric oxide concentration after bariatric surgery—a potential mechanism for cardiovascular benefit. Obes Surg. 2010;20:204–10.

    Article  PubMed  Google Scholar 

  20. World Medical Association Declaration of Helsinki. Bull of the World Health Organization. 2001;79(4):373–4.

    Google Scholar 

  21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem. 1972;18:499–500.

    PubMed  CAS  Google Scholar 

  22. Ghasemi A, Hedayati M, Biabani H. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. J Med Sci Res. 2007;2:29–32.

    Google Scholar 

  23. Miranda K, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide: Biol and Chem. 2001;5(1):62–71.

    Article  CAS  Google Scholar 

  24. Ozcan E. A new automated colorimetric method for measuring total oxidant status. Clinical Biochem. 2005;38(12):1103–11.

    Article  Google Scholar 

  25. Ozcan E. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochem. 2004;37:112–9.

    Article  Google Scholar 

  26. Codoner-Franch P, Tavárez-Alonso S, Murria-Estal R, et al. Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation. Atherosclerosis. 2011;215:475–80.

    Article  PubMed  CAS  Google Scholar 

  27. Da Silva VRG, Moreira EAM, Wilhelm-Filho D et al. Proinflammatory and oxidative stress markers in patients submitted to Roux-en-Y gastric bypass after 1 year of follow-up. European Journal of Clinical Nutrition. 2012; 1–9

  28. Choi WJ, Pai SH, Kim SK, et al. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem. 2001;47(6):1106–9.

    PubMed  CAS  Google Scholar 

  29. Cabrera EJ, Valezi AC, Delfino VDA, et al. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux en-Y gastric bypass. Obes Surg. 2010;20:42–9.

    Article  Google Scholar 

  30. Maniscalco M, de Laurentiis G, Zedda A, et al. Exhaled nitric oxide in severe obesity: effect of weight loss. Respir Physiol & Neurobiol. 2007;156:370–3.

    Article  CAS  Google Scholar 

  31. van Dielen FMH, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89:4062–8.

    Article  PubMed  Google Scholar 

  32. Pardina E, Ferrer R, Baena-Fustegueras JA. Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery. Obes Surg. 2012;22:131–9.

    Article  PubMed  Google Scholar 

  33. Pardina E, Lecube A, Llamas R, et al. Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients. Obes Surg. 2009;19:1150–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the research grant from the National Council for Scientific Research in Romanian Higher Education CNCSIS TD code 409 (80/1.10.2007). This study has been presented at the 16th World Congress of IFSO, Hamburg, Germany, Sept. 1–3, 2011. The authors express their great gratitude to Professor Mervyn Deitel, MD, and to Anna Maria Wolf, MD, for their suggestions on the manuscript.

Conflict of Interest

All authors, Adriana Florinela Cătoi, Alina Pârvu, Romeo Florin Galea, Ioana Delia Pop, Adriana Mureşan, and Cornel Cătoi, declare that they have no conflict of interests to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alina Pârvu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cătoi, A.F., Pârvu, A., Galea, R.F. et al. Nitric Oxide, Oxidant Status and Antioxidant Response in Morbidly Obese Patients: the Impact of 1-Year Surgical Weight Loss. OBES SURG 23, 1858–1863 (2013). https://doi.org/10.1007/s11695-013-0968-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-013-0968-1

Keywords

Navigation